|
1
|
Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques.
|
Circulation
|
2008
|
2.12
|
|
2
|
Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.98
|
|
3
|
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.
|
Blood
|
2010
|
1.86
|
|
4
|
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.
|
J Clin Invest
|
2013
|
1.61
|
|
5
|
Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions.
|
Cardiovasc Res
|
2009
|
1.57
|
|
6
|
T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.
|
Am J Pathol
|
2002
|
1.45
|
|
7
|
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
|
Circulation
|
2007
|
1.35
|
|
8
|
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.31
|
|
9
|
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.22
|
|
10
|
TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.21
|
|
11
|
CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.05
|
|
12
|
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
|
Circulation
|
2002
|
1.00
|
|
13
|
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance.
|
Proc Natl Acad Sci U S A
|
2014
|
0.94
|
|
14
|
Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response.
|
FASEB J
|
2011
|
0.94
|
|
15
|
Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.
|
Eur Heart J
|
2012
|
0.91
|
|
16
|
Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
|
Cardiovasc Res
|
2013
|
0.88
|
|
17
|
Circulating levels of interleukin-1 family cytokines in overweight adolescents.
|
Mediators Inflamm
|
2010
|
0.88
|
|
18
|
Lack of invariant natural killer T cells affects lipid metabolism in adipose tissue of diet-induced obese mice.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.87
|
|
19
|
Macrophage migration inhibitory factor is elevated in obese adolescents.
|
Arch Physiol Biochem
|
2012
|
0.78
|
|
20
|
Levels of Th2 chemokine CCL27 in adolescents: no impact of obesity.
|
Pediatr Allergy Immunol
|
2009
|
0.75
|
|
21
|
Immune-mediated and lipid-mediated platelet function in atherosclerosis.
|
Curr Opin Lipidol
|
2015
|
0.75
|
|
22
|
Atherosclerosis: cell biology and lipoproteins-focus on anti-inflammatory mechanisms as therapeutic options.
|
Curr Opin Lipidol
|
2013
|
0.75
|
|
23
|
Atherosclerosis: cell biology and lipoproteins focus on epigenetic modification and macrophage biology.
|
Curr Opin Lipidol
|
2017
|
0.75
|
|
24
|
Atherosclerosis: cell biology and lipoproteins.
|
Curr Opin Lipidol
|
2010
|
0.75
|
|
25
|
Atherosclerosis: cell biology and lipoproteins-focus on CD40 signaling, PCSK9, and novel animal models.
|
Curr Opin Lipidol
|
2015
|
0.75
|
|
26
|
Atherosclerosis: cell biology and lipoproteins-focus on interleukin-18 signaling, chemotactic heteromers, and microRNAs.
|
Curr Opin Lipidol
|
2016
|
0.75
|
|
27
|
Atherosclerosis: cell biology and lipoproteins focus on iNKT cells and CD40/CD40L in atherosclerosis and metabolic disorders.
|
Curr Opin Lipidol
|
2014
|
0.75
|